Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
NCT06369961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151
Last updated 2024-04-17
Summary
The goal of this observational study is to investigate the correlation and quantitative relationship between the analgesic effect of fentanyl transdermal patches in cancer pain patients and their nutritional status.
Conditions
- Cancer Pain
- Nutrition Disorders
Interventions
- DRUG
-
transdermal fentanyl
Adult cancer pain patients switched from oral opioid to TDF
Sponsors & Collaborators
-
Chongqing University Cancer Hospital
lead OTHER
Principal Investigators
-
Chao Li · Chongqing University Cancer Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2023-07-31
- Completion
- 2023-12-31
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Individualized Pharmaceutical-care in Outpatients With Cancer Pain
NCT03439904 ·Status: UNKNOWN ·Phase: NA
-
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 ·Status: UNKNOWN ·Phase: NA
-
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
NCT00666211 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
NCT00262678 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
NCT00263575 ·Status: COMPLETED ·Phase: PHASE3
-
Analgesic Treatment for Cancer Pain in South East Asia
NCT02664987 ·Status: COMPLETED
-
A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain
NCT00644787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
NCT00634010 ·Status: TERMINATED ·Phase: PHASE3
-
Methadone Versus Morphine for Cancer-Related Pain
NCT00573937 ·Status: TERMINATED ·Phase: PHASE2
-
A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
NCT02289261 ·Status: COMPLETED ·Phase: PHASE4
-
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
NCT01885182 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
NCT00478101 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
NCT00101621 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain
NCT04713189 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)
NCT00362583 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
NCT00647127 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).
NCT00576017 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Methadone As Co-Opioid Analgesic
NCT00558870 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
NCT05674240 ·Status: COMPLETED
-
Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment
NCT05558397 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain
NCT02687347 ·Status: UNKNOWN ·Phase: PHASE3
-
An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics
NCT01060124 ·Status: COMPLETED ·Phase: PHASE4
-
Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
NCT01816503 ·Status: COMPLETED
-
Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269737 ·Status: COMPLETED ·Phase: PHASE3
-
Sublingual Fentanyl for the Management of Breakthrough Pain
NCT02514252 ·Status: TERMINATED ·Phase: PHASE2